Cargando…
820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Oxford University Press
2014
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781668/ http://dx.doi.org/10.1093/ofid/ofu052.528 |
| _version_ | 1783295009646182400 |
|---|---|
| author | Brunetto, Maurizia Rana, Khurram Taliani, Gloria Lawitz, Eric Hézode, Christophe Marcellin, Patrick Serfaty, Lawrence Cohen, David Srinivasan, Subasree |
| author_facet | Brunetto, Maurizia Rana, Khurram Taliani, Gloria Lawitz, Eric Hézode, Christophe Marcellin, Patrick Serfaty, Lawrence Cohen, David Srinivasan, Subasree |
| author_sort | Brunetto, Maurizia |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-5781668 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2014 |
| publisher | Oxford University Press |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-57816682018-03-01 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b Brunetto, Maurizia Rana, Khurram Taliani, Gloria Lawitz, Eric Hézode, Christophe Marcellin, Patrick Serfaty, Lawrence Cohen, David Srinivasan, Subasree Open Forum Infect Dis IDWeek 2014 Abstracts Oxford University Press 2014-12 2014-12 /pmc/articles/PMC5781668/ http://dx.doi.org/10.1093/ofid/ofu052.528 Text en © The Author 2014. Published by Oxford University Press on behalf of the Infectious Diseases Society of America |
| spellingShingle | IDWeek 2014 Abstracts Brunetto, Maurizia Rana, Khurram Taliani, Gloria Lawitz, Eric Hézode, Christophe Marcellin, Patrick Serfaty, Lawrence Cohen, David Srinivasan, Subasree 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b |
| title | 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b |
| title_full | 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b |
| title_fullStr | 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b |
| title_full_unstemmed | 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b |
| title_short | 820 Triple Combination Treatment With Peginterferon Lambda-1a, Daclatasvir and Ribavirin for 12 Weeks in Patients Infected With HCV Genotype 1b |
| title_sort | 820 triple combination treatment with peginterferon lambda-1a, daclatasvir and ribavirin for 12 weeks in patients infected with hcv genotype 1b |
| topic | IDWeek 2014 Abstracts |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5781668/ http://dx.doi.org/10.1093/ofid/ofu052.528 |
| work_keys_str_mv | AT brunettomaurizia 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT ranakhurram 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT talianigloria 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT lawitzeric 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT hezodechristophe 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT marcellinpatrick 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT serfatylawrence 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT cohendavid 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b AT srinivasansubasree 820triplecombinationtreatmentwithpeginterferonlambda1adaclatasvirandribavirinfor12weeksinpatientsinfectedwithhcvgenotype1b |